Literature DB >> 1101801

[Protective effects of bacterial immunostimulants in mice infected by "Klebsiella pneumoniae" resistant to antibiotics after mutation or by plasmid transfer].

M Parant, F Parant, L Chedid, L L Minor.   

Abstract

A streptomycin-resistant strain of K. pneumoniae obtained after mutation in vitro was found to be less virulent than the sensitive strain in mice. However, a single injection of lipopolysaccharides (LPS) administered 24 hours before challenge increased the host's resistance to both strains. In contrast, the virulence was not changed in K. pneumoniae accepting R-factors for ampicillin, streptomycin, chloramphenicol, tetracycline and sulphonamide. The plasmids were transferred to K. pneumoniae from two strains of Escherichia coli possessing different R-factors with the same resistance pattern. As in the first case, mice pretreated by endotoxin were protected against a challenge by microorganisms carrying R-factors. The capacity of the stimulated host to destory resistant or sensitive organisms was of the same order. Klebsiella recovered 5 or 24 hours after infection from the blood, liver and spleen did not lost their antibiotic-resistance. In this study, BCG and Corynebacterium granulosum were also used. Like LPS, these two immunostimulants protected very effectively mice infected with K. pneumoniae rendered resistant to antibiotics by R-factor transfer.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1101801

Source DB:  PubMed          Journal:  Ann Immunol (Paris)        ISSN: 0300-4910


  4 in total

1.  Failure of endotoxin to increase nonspecific resistance to infection of lipopolysaccharide low-responder mice.

Authors:  L Chedid; M Parant; C Damais; F Parant; D Juy; A Galelli
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  Biological activities of endotoxins detoxified by alkylation.

Authors:  L Chedid; F Audibert; C Bona; C Damais; F Parant; M Parant
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

3.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

4.  Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.

Authors:  L Chedid; M Parant; F Parant; F Audibert; F Lefrancier; J Choay; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.